|

Eflornithine (Dose Level 1) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: DFMO

Pipeline

Phase 1: 1

Top Sponsors

  • Orbus Therapeutics, Inc.1

Indications

  • Astrocytoma, IDH-Mutant1
  • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype1
  • Glioblastoma, IDH-Wildtype1
  • GBM1
  • Astrocytoma1

Birmingham, Alabama1 trial

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

University of Alabama at Birmingham

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.